The novel insights derived from our XAI model shed light on the strong impacts of B cells, CD8+ T cells, and NK T cells, along with M0 macrophages on the survival chances of patients with breast cancer and reveal their critical inflection points for designing innovative strategies to reprogram the TME. This evidence concerns the gene CD8A and breast carcinoma.